230 related articles for article (PubMed ID: 27107594)
1. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
2. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors.
Edfeldt K; Ahmad T; Åkerström G; Janson ET; Hellman P; Stålberg P; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):275-84. PubMed ID: 24351681
[TBL] [Abstract][Full Text] [Related]
3. EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine.
Barazeghi E; Hellman P; Norlén O; Westin G; Stålberg P
Sci Rep; 2021 Nov; 11(1):22733. PubMed ID: 34815475
[TBL] [Abstract][Full Text] [Related]
4. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
Barazeghi E; Prabhawa S; Norlén O; Hellman P; Stålberg P; Westin G
BMC Cancer; 2018 Jul; 18(1):764. PubMed ID: 30045709
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
[TBL] [Abstract][Full Text] [Related]
6. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors.
Sei Y; Feng J; Zhao X; Forbes J; Tang D; Nagashima K; Hanson J; Quezado MM; Hughes MS; Wank SA
Gastroenterology; 2016 Jul; 151(1):140-51. PubMed ID: 27003604
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.
Li SC; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
PLoS One; 2015; 10(5):e0125553. PubMed ID: 25942502
[TBL] [Abstract][Full Text] [Related]
9. Roles of miR-196a on gene regulation of neuroendocrine tumor cells.
Li SC; Shi H; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
Mol Cell Endocrinol; 2015 Sep; 412():131-9. PubMed ID: 26052033
[TBL] [Abstract][Full Text] [Related]
10. PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors.
Barazeghi E; Hellman P; Westin G; Stålberg P
Endocr Connect; 2019 Aug; 8(8):1126-1135. PubMed ID: 31349215
[TBL] [Abstract][Full Text] [Related]
11. Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
Nieser M; Henopp T; Brix J; Stoß L; Sitek B; Naboulsi W; Anlauf M; Schlitter AM; Klöppel G; Gress T; Moll R; Bartsch DK; Heverhagen AE; Knoefel WT; Kaemmerer D; Haybaeck J; Fend F; Sperveslage J; Sipos B
Neuroendocrinology; 2017; 104(3):302-312. PubMed ID: 27222126
[TBL] [Abstract][Full Text] [Related]
12. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.
Heverhagen AE; Legrand N; Wagner V; Fendrich V; Bartsch DK; Slater EP
Neuroendocrinology; 2018; 106(4):312-317. PubMed ID: 28848144
[TBL] [Abstract][Full Text] [Related]
14. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
[TBL] [Abstract][Full Text] [Related]
15. GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.
Zanini S; Giovinazzo F; Alaimo D; Lawrence B; Pfragner R; Bassi C; Modlin I; Kidd M
Cell Signal; 2015 May; 27(5):899-907. PubMed ID: 25701539
[TBL] [Abstract][Full Text] [Related]
16. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
17. Tissue- and cell-specific properties of enterochromaffin cells affect the fate of tumorigenesis toward nonendocrine adenocarcinoma of the small intestine.
Sei Y; Feng J; Zhao X; Dagur P; McCoy JP; Merchant JL; Wank SA
Am J Physiol Gastrointest Liver Physiol; 2023 Mar; 324(3):G177-G189. PubMed ID: 36537709
[TBL] [Abstract][Full Text] [Related]
18. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of SST
Klomp MJ; Refardt J; van Koetsveld PM; Campana C; Dalm SU; Dogan F; van Velthuysen MF; Feelders RA; de Herder WW; Hofland J; Hofland LJ
Front Endocrinol (Lausanne); 2023; 14():1184436. PubMed ID: 37223009
[TBL] [Abstract][Full Text] [Related]
20. Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
Gao F; Zafar MI; Jüttner S; Höcker M; Wiedenmann B
Med Sci Monit; 2018 Nov; 24():8125-8140. PubMed ID: 30420588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
